Ischemia-modified albumin and total antioxidant status in patients with slow coronary flow: A pilot observational study;Yavaş koroner akımın görüldüǧü hastalarda iskeminin deǧişikliǧe uǧrattıǧı albümin ve total antioksidan durum: Gözlemsel bir pilot çalışma

Anadolu Kardiyoloji Dergisi

Volumn 11, Issue 7, 2011, Pages 582-587

  Koç, Fatih ^a   Erdem, Sami ^b   Altunkaş, Fatih ^a   Özbek, Kerem ^a   Gül, Enes Elvin ^b   Kurban, Sevil ^b   Taşyürek, Erkan ^b   Erbay, Ekrem ^b   Söǧüt, Erkan ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Antioxidant status; Ischemia modified albumin; Slow coronary flow

Indexed keywords

ANTIOXIDANT; ISCHEMIA MODIFIED ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; ISCHEMIA MODIFIED ALBUMIN BLOOD LEVEL; MALE; OBSERVATIONAL STUDY; PILOT STUDY; SLOW CORONARY FLOW; TOTAL ANTIOXIDANT STATUS;

EID: 80054691079     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2011.159     Document Type: Article

References (45)

1. Çamsari{dotless} A, Özcan T, Özer C, Akçay B. Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis 2008; 200: 310-4. [CrossRef]
2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J 1972; 84: 66-71. [CrossRef]
3. Shirani S, Darabian S, Jozaghi S, Hamidian R. Correlation between endothelial dysfunction in normal coronary patients with slow flow and aortic ectasia: the first report. Cardiol J 2009; 16: 146-50.
4. Erdoǧan D, Cali{dotless}şkan M, Güllü H, Sezgin AT, Yi{dotless}ldi{dotless}ri{dotless}r A, Müderrisoǧlu H. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis 2007; 191: 168-74.
5. Fineschi M, Bravi A, Gori T. The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances. Int J Cardiol 2008; 127: 358-61. [CrossRef]
6. Sezgin AT, Si{dotless}ǧi{dotless}rci{dotless} A, Barutçu I, Topal E, Sezgin N, Özdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003; 14: 155-61. [CrossRef]
7. Şen N, Özlü MF, Başar N, Özcan F, Güngör O, Turak O, et al. Relationship between elevated serum gamma-glutamyltransferase activity and slow coronary flow. Türk Kardiyol Dern Arş 2009; 37: 168-73.
8. Akçay A, Acar G, Kurutaş E, Sökmen A, Atli{dotless} Y, Nacar AB, et al. Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coronary flow. Türk Kardiyol Dern Arş 2010; 38: 244-9.
9. Thérond P, Bonnefont-Rousselot D, Davit-Spraul A, Conti M, Legrand A. Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care 2000; 3: 373-84.
10. Flores-Mateo G, Carrillo-Santisteve P, Elosua R, Guallar E, Marrugat J, Bleys J, et al. Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies. Am J Epidemiol 2009; 170: 135-47. [CrossRef]
11. Jain AP, Mohan A, Gupta OP, Jajoo UN, Kalantri SP, Srivastava LM. Role of oxygen free radicals in causing endothelial damage in acute myocardial infarction. J Assoc Physicians India 2000; 48: 478-80.
12. LoPresti R, Catania A, D'Amico T, Montana M, Caruso M, Caimi G. Oxidative stress in young subjects with acute myocardial infarction: evaluation at the initial stage and after 12 months. Clin Appl Thromb Hemost 2008; 14: 421-7. [CrossRef]
13. Kazanis K, Dalamaga M, Nounopoulos C, Manolis AS, Sakellaris N, Jullien G, et al. Ischemia modified albumin, high-sensitivity C-reactive protein and natriuretic peptide in patients with coronary atherosclerosis. Clin Chim Acta 2009; 408: 65-9. [CrossRef]
14. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemiamodified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003; 107: 2403-5. [CrossRef]
15. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin-I. Am Heart J 2001; 141: 985-91. [CrossRef]
16. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of "ischemia-modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21: 29-34. [CrossRef]
17. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischemia modified albumin. Heart 2006; 92: 113-4. [CrossRef]
18. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6. [CrossRef]
20. Bar-Or D, Lau E, Winkler JV. A Novel assay for cobalt-albumin binding and its potential as a marker for myocardi{dotless}al i{dotless}schemi{dotless}a-a preli{dotless}mi{dotless}nary report. J Emerg Med 2000; 4: 311-5. [CrossRef]
21. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 2007; 45: 261-2. [CrossRef]
22. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85.
23. Enli Y, Türk M, Akbay R, Evrengül H, Tanri{dotless}verdi H, Kuru O, et al. Oxidative stress parameters in patients with slow coronary flow. Adv Ther 2008; 25: 37-44. [CrossRef]
24. Avşar O, Demir I, Ekiz O, Altekin RE, Yalçi{dotless}nkaya S. Relationship between the slow coronary flow and carotid artery intima-media thickness. Anadolu Kardiyol Derg 2007; 7: 19-23.
25. Tanri{dotless}verdi H, Evrengül H, Tanri{dotless}verdi S, Kuru O, Seleci D, Enli Y, et al. Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels. Coron Artery Dis 2006; 17: 331-7. [CrossRef]
26. Yaymaci{dotless} B, Daǧdelen S, Bozbuǧa N, Demirkol O, Say B, Güzelmeriç F, et al. The response of the myocardial metabolism to atrial pacing in patients with coronary slow flow. Int J Cardiol 2001; 78: 151-6. [CrossRef]
27. Lubrano V, Di Cecco P, Zucchelli GC. Role of superoxide dismutase in vascular inflammation and in coronary artery disease. Clin Exp Med 2006; 6: 84-8. [CrossRef]
28. Fujimoto H, Taguchi J, Imai Y, Ayabe S, Hashimoto H, Kobayashi H, et al. Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur Heart J 2008; 29: 1267-74.
29. Schwenke DC. Antioxidants and atherogenesis. J Nutr Biochem 1998; 9: 424-5. [CrossRef]
30. Sezen Y, Baş M, Polat M, Yi{dotless}ldi{dotless}z A, Büyükhatipoǧlu H, Küçükdurmaz Z, et al. The relationship between oxidative stress and coronary artery ectasia. Cardiol J 2010;17:488-94.
31. Nikolic-Heitzler V, Rabuzin F, Tatzber F, Vrkic N, Bulj N, Borovic S, et al. Persistent oxidative stress after myocardial infarction treated by percutaneous coronary intervention. Tohoku J Exp Med 2006; 210: 247-55. [CrossRef]
32. Yao D, Vlessidis AG, Evmiridis NP, Siminelakis S, Dimitra N. Possible mechanism for nitric oxide and oxidative stress induced pathophysiological variance in acute myocardial infarction development. A study by a flow injection-chemiluminescence method. Anal Chim Acta 2004; 505: 115-23. [CrossRef]
33. Türedi S, Karahan SC, Menteşe A, Gündüz A, Topbaş M, Koşucu P, et al. Investigation of relationship between the D-dimer and ischemia-modified albumin levels with the radiological imagingbased pulmonary embolism severity score in acute pulmonary embolism. Anadolu Kardiyol Derg 2010; 10: 346-52. [CrossRef]
34. Üstün Y, Engin-Üstün Y, Öztürk O, Alanbay I, Yaman H. Ischemiamodified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med 2011; 24: 418-21. [CrossRef]
35. Kalay N, Çetinkaya Y, Başar E, Muhtaroǧlu S, Özdoǧru I, Gül A, et al. Use of ischemia-modified albumin in diagnosis of coronary artery disease. Coron Artery Dis 2007; 18: 633-7. [CrossRef]
36. Liyan C, Jie Z, Yonghua W, Xiaozhou H. Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes. J Clin Lab Anal 2008; 22: 45-9. [CrossRef]
37. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003; 107: 2403-5. [CrossRef]
38. Gündüz A, Türedi S, Menteşe A, Karahan SC, Hoş G, Tatli{dotless} O, et al. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med 2008; 26: 202-5.
39. Gündüz A, Türedi S, Menteşe A, Altunayoǧlu V, Turan I, Karahan SC, et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008; 26: 874-8.
40. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis 2006; 47: 493-502. [CrossRef]
41. Xanthos T, Iacovidou N, Pantazopoulos I, Vlachos I, Bassiakou E, Stroumpoulis K, et al. Ischemia-modified albumin predicts the outcome of cardiopulmonary resuscitation: An experimental study. Resuscitation 2010; 81: 591-5. [CrossRef]
42. Demirkol MO, Yaymaci B, Mutlu B. Dipyridamole myocardial perfusion single photon emission computed tomography in patients with slow coronary flow. Coron Artery Dis 2002; 13: 223-9. [CrossRef]
43. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology 2001; 52: 507-14. [CrossRef]
44. Pilz G, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P. Angiographic correlations of patients with small vessel disease diagnosed by adenosine-stress cardiac magnetic resonance imaging. J Cardiovasc Magn Reson 2008; 10: 8. [CrossRef]
45. Piva SJ, Duarte MM, Da Cruz IB, Coelho AC, Moreira AP, Tonello R, et al. Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clin Biochem 2011; 44: 345-7. [CrossRef]